Focus on Managed Care Pharmacy

(M1) The Present and Future of Specialty Drug Management Strategies

Wednesday, October 21, 2020

11:00am – 12:00pm

ACPE UAN:0233-0000-20-048-L04-P | Contact Hours: 1 | Activity Type:
Knowledge-based

Faculty(s)

Eric Cannon, PharmD, FAMCP

Chief Pharmacy Officer
SelectHealth
Murray, Utah
Dino Conti, PharmD, MBA

AVP Health Plan Pharmacy Consulting
Solid Benefit Guidance
Montvale, New Jersey
Babette S. Edgar, PharmD, MBA, FAMCP

Senior Area Vice President
BluePeak Advisors
Bartonville, Texas
Tasmiya Khan, PharmD

Area Vice President
Solid Benefit Guidance
Astoria, New York

Specialty medications continue to make up a significant portion of health care expenditures across the pharmacy and medical benefit each year. The management strategies applied across the landscape of payers are dynamic and come in many shapes and sizes. Some of these strategies are designed to have short-term results, some long-term, and yet others have industry changing impact.

Managing overall drug spend takes a multipronged approach. There are key findings for successfully implementing specialty management strategies that can be of value from a payer perspective.

This session will take a high level look at how specialty medications are being managed across the payer landscape and discuss what strategies work and have the best outcomes. In addition, this session will discuss potential innovations with the most promise.

Learning Objectives: :

At the completion of this activity, participants should be able to:

Identify at least one current challenge facing payers when managing specialty medications.
Discuss at least two management strategies that are highly successful in managing specialty drug spend and the rationale.
Describe at least one strategy that can help payers prepare for future specialty drug trend management.